Table 2.
Relationship between the BMI loss and the clinical characteristics in 615 patients with esophageal cancer
| Characteristics | Overall (n=615) | BMI loss | p-value | ||
|---|---|---|---|---|---|
| 0(%)(n=365) | ≤2(%)(n=207) | ＞2(%)(n=43) | |||
| Histopathology | |||||
| ESCC | 446(72.5) | 266(72.9) | 151(72.9) | 29(67.4) | 0.741 |
| Non-ESCC | 169(27.5) | 99(27.1) | 56(27.1) | 14(32.6) | |
| Small cell carcinoma | 63(37.3) | 36(36.4) | 24(42.9) | 3(21.4) | 0.689 |
| Adenocarcinoma | 46(27.2) | 30(30.3) | 14(25.0) | 2(14.3) | |
| Gender | |||||
| Male | 474(77.1) | 279(76.4) | 162(78.3) | 33(76.7) | 0.882 |
| Female | 141(22.9) | 86(23.6) | 45(21.7) | 10(23.3) | |
| Age | |||||
| ≤59 years | 314(51.1) | 170(47.8) | 112(54.1) | 23(50.3) | 0.317 |
| >59 years | 301(48.9) | 186(52.2) | 95(45.9) | 20(49.7) | |
| Alcohol | |||||
| Never | 375(62.0) | 230(63.0) | 124(59.9) | 21(61.0) | 0.183 |
| Ever | 240(38.0) | 135(37.0) | 83(40.1) | 22(39.0) | |
| Smoking | |||||
| Never | 217(35.3) | 136(37.3) | 67(32.4) | 14(35.3) | 0.464 |
| Ever | 398(64.7) | 229(62.7) | 140(67.6) | 29(64.7) | |
| Diabetes mellitus | |||||
| No | 587(95.4) | 348(95.3) | 197(95.2) | 42(95.4) | 0.765 |
| Yes | 28(4.6) | 17(4.7) | 10(4.8) | 1(4.6) | |
| Hypertension | |||||
| No | 453(73.7) | 266(72.9) | 151(72.9) | 36(83.7) | 0.299 |
| Yes | 162(26.3) | 99(27.1) | 56(27.1) | 7(16.3) | |
| Anemia | |||||
| No | 548(89.1) | 333(91.2) | 184(88.9) | 31(72.1) | 0.001 |
| Yes | 67(11.9) | 32(8.8) | 23(11.1) | 12(27.9) | |
| Family history | |||||
| No | 499(81.1) | 291(79.7) | 169(81.6) | 39(90.7) | 0.215 |
| Yes | 116(19.9) | 74(20.3) | 38(18.4) | 4(9.3) | |
| Location | |||||
| Up | 56(9.1) | 32(8.8) | 21(10.1) | 3(7.0) | 0.477 |
| Middle | 380(61.8) | 235(64.4) | 121(58.5) | 24(55.8) | |
| Low | 179(29.1) | 98(26.8) | 65(31.4) | 16(37.2) | |
| Stage | |||||
| I and II | 320(52.0) | 208(57.0) | 92(44.4) | 20(52.0) | 0.012 |
| III and IV | 295(48.0) | 157(43.0) | 115(55.6) | 23(48.0) | |
| Treatment | |||||
| CHO+RAD | 36(5.8) | 16(1.7) | 15(7.2) | 5(11.6) | 0.001 |
| Surgery only | 324(52.7) | 200(56.3) | 99(47.8) | 25(58.1) | |
| SUR+CHO+RAD | 255(41.5) | 149(42.0) | 93(44.9) | 13(30.2) | |
Note: Bold values indicate significant differences (p<0.05).
Abbreviations: BMI, body mass index; CHO+RAD, chemotherapy and radiotherapy; SUR+CHO+RAD, surgery and chemotherapy and radiotherapy; ESCC, esophageal squamous cell carcinoma.